Pill Burden in Patients With Type 2 Diabetes in Germany: Subanalysis From the Prospective, Noninterventional PROVIL Study
Author:
Affiliation:
1. Universitätsklinikum [University Medical Center], Leipzig, Germany
2. Kantar Health GmbH, Munich, Germany
3. Clinical and Regulatory Affairs, Novartis Pharma GmbH, Nürnberg, Germany
Abstract
Publisher
American Diabetes Association
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://diabetesjournals.org/clinical/article-pdf/33/2/55/500422/55.pdf
Reference17 articles.
1. IDF Diabetes Atlas;International Diabetes Federation,2013
2. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012
3. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes;Morrish;Diabetologia,2001
4. Diabetes, other risk factors and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial;Stamler;Diabetes Care,1993
5. Predictors of adherence with antihypertensive and lipid-lowering therapy;Chapman;Arch Intern Med,2005
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Phase III study of bilayer sustained-release tramadol tablets in patients with cancer pain: a double-blind parallel-group, non-inferiority study with immediate-release tramadol capsules as an active comparator;Supportive Care in Cancer;2023-12-29
2. Continuous Glucose Monitoring – offering empowerment and self-care agency for type 1 diabetes patients;Salud, Ciencia y Tecnología;2023-10-17
3. Measuring treatment burden in people with Type 2 Diabetes Mellitus (T2DM): A Mixed-methods Systematic Review;2023-09-11
4. An Analysis of Medication Adherence in a Large Outpatient Population During the COVID-19 Pandemic Using a Novel Value-Based Pharmacy System;Telemedicine and e-Health;2023-08-07
5. Impact of Reduction in Pill Load Upon Use of a Once Weekly DPP-4 Inhibitor in 2 Cases of Type 2 Diabetes;Asploro Journal of Biomedical and Clinical Case Reports;2022-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3